Table 1.
Clinical characteristics in 153 esophageal squamous cell carcinoma patients
| Variables | Categories | No. of patients (%) |
|---|---|---|
| Gender | Male | 128 (83.66) |
| Female | 25 (16.34) | |
| Age | Year | 61.93 ± 6.72 |
| Tobacco | Yes | 66 (43.14) |
| No | 87 (56.86) | |
| Alcohol | Yes | 57 (37.25) |
| No | 96 (62.75) | |
| Hypertension | Yes | 13 (8.50) |
| No | 140 (91.50) | |
| Diabetes | Yes | 2 (1.31) |
| No | 151 (98.69) | |
| Tumor stage | 0–II | 79 (51.63) |
| III | 74 (48.37) | |
| Depth of invasion | T1–T2 | 38 (24.84) |
| T3 | 115 (75.16) | |
| Lymph node | N0 | 79 (51.63) |
| N1–N3 | 74 (48.37) | |
| Differentiation | Well-moderate | 123 (80.39) |
| Poor | 30 (19.61) | |
| Tumor size (cm) | ≤ 4 | 109 (71.24) |
| > 4 | 44 (28.76) | |
| Radio-chemotherapy | Yes | 92 (60.13) |
| No | 61 (39.87) | |
| NLR | 2.88 (0.16–14.40) | |
| dNLR | 3.52 (0.01–24.07) | |
| PLR | 137.47 (8.38–673.68) | |
| LMR | 5.17 (1.03–65.40) | |
| Fib | mg/dL | 3.29 (1.8–5.42) |
| Alb | g/L | 40.4 (22.8–49.8) |
| AFR | 12.13 (5.74–22.15) | |
| ADS | Low | 87 (56.86) |
| High | 66 (43.14) |
NLR neutrophil to lymphocytes ratio, dNLR derived neutrophil to lymphocyte ratio, PLR platelet to lymphocyte ratio, LMR lymphocyte to monocyte ratio, Fib fibrinogen, Alb albumin, AFR albumin to fibrinogen ratio, ADS AFR–Alb–dNLR score